Patients eat less, feel fuller for longer and burn more energy, which may explain the promising results seen in trials
Semaglutide is not recommended for candidates who are pregnant, breastfeeding, are already taking a different GLP-1 medication, or have certain diseases or allergic reactionswe will let you know the specifics of these parameters when we meet with you to discuss your treatment
Feel beautiful, naturally
After matching on propensity scores, the groups had very similar baseline demographic characteristics, cardiometabolic health issues, laboratory measures, and health care use, allowing for more reliable comparisons between the treatment groups
Another drawback is that people start to regain weight once they stop taking GLP-1 drugs